COM:CYTOMX
CytomX Therapeutics
- Stock
Last Close
0.87
22/11 21:00
Market Cap
102.07M
Beta: -
Volume Today
1.23K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.06 - | 0.07 10.99% | 0.04 43.73% | 0.08 93.19% | 0.18 138.43% | 0.13 27.73% | 0.17 29.41% | 0.28 66.12% | 0.20 26.75% | 0.20 0.59% | 0.49 142.11% | |
cash conversion cycle | -232.30 - | |||||||||||
cash per share | 0.25 - | 1.84 639.93% | 21.72 1,078.11% | 5.02 76.89% | 10.07 100.47% | 10.47 3.99% | 6.53 37.60% | 6.85 4.87% | 4.76 30.54% | 2.95 38.09% | 2.36 19.74% | |
company equity multiplier | -0.32 - | -0.93 190.42% | 1.56 268.17% | 2.54 62.20% | 5.69 124.21% | 3.49 38.61% | 6.68 91.18% | 7.20 7.86% | 3.80 47.27% | -3.04 180.12% | -4.32 42.12% | |
days of inventory outstanding | ||||||||||||
days of payables outstanding | 244.68 - | |||||||||||
days of sales outstanding | 97.42 - | 134.80 38.38% | 35.21 73.88% | 56.12 59.38% | 51.67 7.93% | 0.60 98.85% | 0.08 86.13% | 2.90 3,416.21% | 4.14 42.81% | 247.07 5,861.26% | 12.38 94.99% | |
dividend yield | 0.04 - | |||||||||||
ebit per revenue | -16.84 - | -5.86 65.19% | -4.31 26.56% | -3.96 8.00% | -0.65 83.69% | -1.31 102.64% | -1.93 47.39% | -0.48 74.89% | -1.20 148.65% | -1.91 58.29% | -0.06 96.64% | |
ebt per ebit | 1.01 - | 1.02 0.61% | 1.07 4.63% | 0.99 7.16% | 0.94 4.65% | 0.90 4.25% | 0.93 2.55% | 0.96 4.00% | 1.00 3.65% | 0.98 1.79% | -0.51 152.29% | |
effective tax rate | -0.00 - | -0.00 50.06% | -0.00 14.32% | 0.00 214.04% | 0.01 3,547.65% | -0.20 1,829.63% | 0.00 102.04% | 0.30 7,047.34% | 0.04 88.09% | 0.02 42.63% | 1.17 5,664.28% | |
enterprise value multiple | -31.36 - | -13.40 57.25% | -3.69 72.49% | -5.29 43.47% | -13.61 157.22% | -5.02 63.10% | -1.92 61.71% | -2.94 52.85% | -1.08 63.33% | 0.69 164.48% | -25.81 3,814.33% | |
fixed asset turnover | 0.43 - | 1.68 292.14% | 2.22 31.70% | 3.43 54.60% | 16.98 395.76% | 8.58 49.46% | 1.76 79.55% | 3.41 94.19% | 2.75 19.39% | 2.53 7.95% | 6.26 147.38% | |
free cash flow per share | -0.25 - | 0.86 444.84% | -3.38 491.09% | -0.12 96.56% | 4.54 4,011.13% | -1.90 141.91% | -3.18 66.84% | 0.06 102.01% | -1.88 3,041.87% | -1.71 8.98% | -0.77 54.98% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.98 2.15% | |
interest coverage | -58.88 - | -61.12 3.80% | -19.17 68.63% | -35.28 84.03% | 50.22 - | |||||||
inventory turnover | ||||||||||||
long term debt to capitalization | -0.07 - | -0.02 71.41% | 0.33 - | 0.30 7.36% | 0.17 44.58% | -0.19 215.85% | -0.25 26.64% | |||||
net income per ebt | 1.00 - | 1.00 0.03% | 1.00 0.00% | 1.00 0.06% | 0.99 1.14% | 1.20 21.78% | 1.00 17.25% | 0.70 29.43% | 0.96 37.26% | 0.98 1.57% | -0.17 117.48% | |
net profit margin | -17.05 - | -5.97 64.99% | -4.59 23.17% | -3.92 14.64% | -0.60 84.63% | -1.42 136.29% | -1.78 25.07% | -0.33 81.58% | -1.16 253.77% | -1.83 57.89% | -0.01 99.69% | |
operating cash flow per share | -0.23 - | 0.91 497.13% | -3.19 450.28% | -0.06 98.24% | 4.58 8,274.23% | -1.81 139.54% | -3.10 70.95% | 0.11 103.68% | -1.86 1,728.21% | -1.69 9.18% | -0.76 54.95% | |
operating cycle | 12.38 - | |||||||||||
operating profit margin | -16.84 - | -5.86 65.19% | -4.31 26.56% | -3.96 8.00% | -0.65 83.69% | -1.31 102.64% | -1.93 47.39% | -0.48 74.89% | -1.20 148.65% | -1.91 58.29% | -0.06 96.64% | |
payables turnover | 1.49 - | |||||||||||
pretax profit margin | -17.04 - | -5.97 64.98% | -4.59 23.17% | -3.92 14.59% | -0.61 84.45% | -1.18 94.03% | -1.79 51.15% | -0.47 73.89% | -1.20 157.73% | -1.87 55.45% | 0.03 101.76% | |
price fair value | -10.17 - | -5.74 43.62% | 1.42 124.81% | 5.07 256.61% | 11.23 121.22% | 4.81 57.18% | 7.37 53.34% | 6.07 17.66% | 3.11 48.80% | -1.23 139.47% | -2.41 96.57% | |
receivables turnover | 3.75 - | 2.71 27.73% | 10.37 282.81% | 6.50 37.26% | 7.06 8.62% | 613.42 8,583.65% | 4.42K 620.91% | 125.77 97.16% | 88.07 29.98% | 1.48 98.32% | 29.49 1,896.26% | |
return on assets | -1.07 - | -0.41 61.14% | -0.18 56.76% | -0.30 64.91% | -0.11 63.36% | -0.19 70.77% | -0.30 61.86% | -0.09 69.39% | -0.24 159.15% | -0.37 56.96% | -0.00 99.26% | |
return on capital employed | -1.49 - | -0.48 67.81% | -0.18 61.95% | -0.36 99.36% | -0.14 62.31% | -0.22 57.70% | -0.43 100.05% | -0.19 56.52% | -0.36 90.60% | -0.94 160.37% | -0.13 85.93% | |
return on equity | 0.34 - | 0.39 12.84% | -0.28 172.71% | -0.75 167.47% | -0.62 17.84% | -0.65 4.83% | -2.00 209.44% | -0.66 66.99% | -0.90 36.65% | 1.13 225.75% | 0.01 98.94% | |
total debt to capitalization | -0.10 - | -0.04 62.30% | 0.09 - | 0.35 279.84% | 0.33 5.20% | 0.20 41.40% | -0.27 236.67% | -0.42 56.51% |
All numbers in USD (except ratios and percentages)